24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
Corporate
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Divestment
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
Corporate
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
12:53
Every student deserves a personal tutor, inside the classroom, too.
09:51
AI companies say their models are the best. Here's how to tell if that's true
08:35
What if the AI runs out of electricity?
13:02
Intel shares plunge 25% as weak forecast rattles investors
More stories
Buzz
Most popular
Daily
Weekly
1
"A gorgeous situation": ServiceNow's CEO celebrates a shrinking workforce
2
Intel shares plunge as Israel factory blast compounds weak outlook
3
Cyber startup Cyera eyes $20 billion valuation in new funding talks
4
Stealth Israeli cyber startup valued at over $1.5 billion recruits former 8200 chief
5
Nikesh Arora's pay falls 19.5% to $80 million as Palo Alto Networks board lowers cap on stock awards
More news
Divestment
7 stories about Divestment
Norwegian wealth fund divests from Israel’s banking sector
26.08.25
|
CTech
Four largest banks targeted for financing settlements; Caterpillar shares also sold.
With No Buyers, Teva to Close Israeli Medical Equipment Plant
09.04.18
|
Dror Reich
The facility in Ashdod is one of five Teva intends to sell or close in its home country
Allergan to Sell Teva Shares to J.P. Morgan
14.11.17
|
Dror Reich and Lilach Baumer
Allergan announced it pledged its 9.8% stake in Teva to J.P. Morgan as collateral, as part of a loan agreement. The company already agreed to sell a quarter of the stock in the first quarter of 2018
Teva Offloads Holdings in Australia’s Mesoblast
25.10.17
|
Dror Reich and Lilach Baumer
The stem-cell therapy company diluted Teva’s shares through a new offering in August
Founding Family Sells Holdings in Online Gambling Company 888
09.10.17
|
Golan Hazani and Lilach Baumer
Co-founder Aaron Shaked’s heirs sold their entire stake for nearly $300 million
Teva Sells Remaining Women's Health Assets
18.09.17
|
Lilach Baumer
After selling its Paragard business for $1.1 billion last week, Teva's remaining Women's Health business will be split between CVC Capital Partners and Foundation Consumer Healthcare in a $1.38 billion cash deal
Teva Negotiating Sale of Remaining Women's Health Assets, Report Says
14.09.17
|
Lilach Baumer
CVC Capital Partners is nearing a $800 million deal for Teva's remaining Women's Health business, Bloomberg reported Thursday